The core risk is economic, not technical: UiPath must prove
orchestration, governance, and testing become recurring production spend before broader software suites make those functions good-enough features. Its installed base, cash, and
gross margins give it time, but pilot-purgatory, pricing migration, and bundled competition limit how aggressive the 2031 case can be.